Literature DB >> 12910364

Radiotherapeutic approaches to metastatic disease.

Edward Chow1, Jackson Wu, Andrew Loblaw, Carlos A Perez.   

Abstract

Bone metastases in patients with prostate cancer are common. Prostate cancer patients also have a relatively long survival. Palliative radiation can provide effective symptom control in many clinical settings. This article focuses on the management of bone pain and its complications (pathological fractures and spinal cord compression) with radiation treatment.

Entities:  

Mesh:

Year:  2003        PMID: 12910364     DOI: 10.1007/s00345-003-0359-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  118 in total

1.  Bone metastasis: review and critical analysis of random allocation trial of local field treatment: regarding Ratanatharathorn et al. IJROB 44(1):1-18; 1999.

Authors:  E Chow; C Danjoux; R Connolly; L Andersson; J Finkelstein; E Szumacher; R Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

2.  FEMORAL METASTASES AND FRACTURES FROM BREAST CANCER.

Authors:  W SNELL; R K BEALS
Journal:  Surg Gynecol Obstet       Date:  1964-07

3.  Nontraumatic avulsion of the lesser trochanter: a pathognomonic sign of metastatic disease?

Authors:  C D Phillips; T L Pope; J E Jones; T E Keats; R H MacMillan
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

4.  Metastasis size in pathologic femoral fractures.

Authors:  H Menck; S Schulze; E Larsen
Journal:  Acta Orthop Scand       Date:  1988-04

Review 5.  Palliative irradiation of bone metastases.

Authors:  H S Poulsen; O S Nielsen; M Klee; M Rørth
Journal:  Cancer Treat Rev       Date:  1989-03       Impact factor: 12.111

6.  Orthopedic management of patients with metastatic carcinoma of the breast.

Authors:  D J Schurman; H C Amstutz
Journal:  Surg Gynecol Obstet       Date:  1973-11

Review 7.  Bone metastasis: review and critical analysis of random allocation trials of local field treatment.

Authors:  V Ratanatharathorn; W E Powers; W T Moss; C A Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-04-01       Impact factor: 7.038

8.  Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.

Authors:  I Malmberg; U Persson; A Ask; J Tennvall; P A Abrahamsson
Journal:  Urology       Date:  1997-11       Impact factor: 2.649

9.  The use of postoperative irradiation for the prevention of heterotopic bone formation after total hip replacement.

Authors:  J E Sylvester; P Greenberg; M T Selch; B J Thomas; H Amstutz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-03       Impact factor: 7.038

10.  Radiotherapeutic management of osseous metastases: a survey of current patterns of care.

Authors:  E Ben-Josef; F Shamsa; A O Williams; A T Porter
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

View more
  2 in total

Review 1.  [Palliative and supportive treatment options in patients with advanced prostate cancer].

Authors:  T Maurer; M Retz; J E Gschwend
Journal:  Urologe A       Date:  2007-01       Impact factor: 0.639

Review 2.  The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.

Authors:  Jim N Rose; Juanita M Crook
Journal:  Ther Adv Urol       Date:  2015-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.